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Chapter 14

Anticoagulant Rodenticides and Wildlife:
Concluding Remarks
Nico W. van den Brink, John E. Elliott, Richard F. Shore,
and Barnett A. Rattner

Rodents are known to affect human society globally in various adverse ways (Chap. 1).
Since historic times, they have been vectors for a wide range of human and livestock
diseases. Almost all agricultural activity worldwide, both past and present, has been
subject to attack and fouling by rodents, which may therefore threaten our ability to
feed ourselves.
More recently, rodents have presented new problems, for example by causing
damage to power supplies and electrical infrastructure, and by colonising (with
inadvertent help from humans) remote islands and predating the eggs and chicks of
what are often rare and endemic species of significant conservation value. The overall result of this multi-faceted conflict with mankind is a widespread demand for
continuous control of commensal rodents, and in some cases other species.
Anticoagulant rodenticides (ARs) have been, and currently remain, the cornerstone of rodent control throughout the world (Chap. 2). Although alternative methods
exist, they are less effective for control of large scale outbreaks or infestations, such
as across agricultural areas. Other reasons further explain why ARs have become a
mainstay of chemical control, and these are related to their mode of toxicity and
pharmacokinetics. Briefly, AR mode of action (and toxicity) involves binding to vitamin K epoxide reductase sites, especially in the liver, and preventing the activation of
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clotting factors, eventually resulting in coagulopathy (Chap. 3). In terms of efficacy
and safety, there are two important beneficial consequences of this mode of toxicity.
First, the delayed onset of physiological effects reduces the likelihood that bait shyness will develop. Second, Vitamin K1 is an effective antidote that mitigates the
action of ARs. Accidental ingestion of ARs by livestock, companion animals, humans
and wildlife can therefore be simply and effectively treated, a key benefit for poisons
that are so widely used and potentially available to non-target organisms.
Anticoagulant rodenticides have the potential to harm a wide range of non-target
species because they affect the blood clotting cascade, a highly conserved physiological mechanism amongst vertebrates. Due to this non-selectivity, their undoubted
benefits for rodent control have to be balanced against the environmental risks that
these compounds pose. There has been significant research effort world-wide in the
last 25 years to better characterise and understand the risks of non-target exposure
and poisoning. In this book, we have brought together and described the current
state of understanding of these risks.
Although ARs have been used for decades, pharmacokinetic and toxicokinetic
data have principally been generated from studies on laboratory mammals and concentrated on acute effects associated with lethal coagulopathy (Chaps. 3 and 4).
There are, therefore, relatively limited laboratory data on other (particularly chronic
and sub-lethal) effects in wildlife species and there are significant gaps in our
knowledge that are relevant for assessing risk to wildlife. An important gap is an
understanding of the cause of the large inter- and intra-species differences in sensitivity to ARs amongst the small number of species that have been tested. It is not
clear where non-target taxa, that may be at most risk of exposure, are ranked within
species-sensitivity distributions. Knowledge and understanding of Vitamin K status
in non-target species as it relates to AR sensitivity, as well as other causal and confounding factors affecting sensitivity, are lacking. Ecological risk assessments for
ARs would be significantly improved with additional knowledge in these areas.
Other major gaps in knowledge include whether there are AR-mediated sub-lethal
effects, unrelated to coagulopathy, that are significant (Chap. 3), the extent and
importance of trans-placental and in ovo transfer of ARs, and the impacts of sequential exposures to ARs as are known to occur in wildlife.
Although there is much we do not know, it is clear that the pharmacokinetics and
toxicity of ARs not only make them effective poisoning agents but also fundamentally mediate the comparative risk that different ARs pose to non-target species
(Chaps. 3 and 4). Studies have shown that second-generation anticoagulant rodenticides (SGARs) are more acutely toxic than first-generation compounds (FGARs),
although the difference in potency is diminished when exposure is chronic. SGARs
are also more persistent in body tissues, with two- to five-fold longer hepatic half-
lives. Differences in acute toxicity among compounds are most likely to affect the
extent to which primary exposure in non-targets results in mortalities. The proliferation of SGAR use over FGARs may have increased the risk of primary poisoning
amongst non-targets in general, and in particular amongst bird species. For example, the differences in acute toxicity of some SGARs (e.g., brodifacoum, d ifethialone)
between birds and mammals are modest when compared with the seemingly large
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differences in toxicity of FGARs between birds and mammals. However, it is the
enhancements both in acute toxicity and tissue half-life in SGARs that are important in determining the extent of secondary exposure and poisoning of predators and
scavengers, and that helps explain why many secondary exposure and poisoning
studies have focussed on SGARs.
The focus of this book is specifically about the impacts of ARs on wildlife, and
the ability to clearly identify AR-mediated effects is fundamental to this topic. The
mere presence of AR residues in tissues demonstrates exposure, but does not indicate that the animal succumbed from AR-mediated effects. A combined approach of
clinical investigation, measurement of blood parameters and detection of tissue residues often can enable unequivocal diagnosis, but there are significant difficulties
(Chap. 5). Knowledge of the pathophysiology of ARs aids in recognizing ante-mortem
and post-mortem toxicosis. Ante-mortem symptoms, such as lethargy, subdued
behaviour and unresponsiveness are generally not very specific. However in combination with observations on changes in blood parameters, such as increased clotting
times, diagnosis is far more apparent. Many studies however rely on examination
not of live animals but on necropsy and measurements of tissue residues in wildlife
carcasses. Symptoms such as pallor of the mucous membranes (e.g., in oral cavity)
can be an indicator of toxicosis, as is the presence of signs of haemorrhage.
Histopathological lesions provide supportive evidence of severe blood loss, haemorrhage, or hypoxic damage, but are not solely indicative of AR toxicosis.
Microscopic evidence of haemorrhage in heart, lung, kidney, liver and skeletal muscle,
and tissue necrosis have also been reported but their prevalence is not always doserelated to AR-exposure. Furthermore, differentiating between haemorrhages resulting
from poisoning as opposed to traumatic injury can be difficult.
Overall, the combining of data obtained through various routes of investigation
and disciplines (e.g., clinical observation and treatment, pathological evaluation and
forensics) will help provide the most complete picture of whether AR-mediated
effects have occurred, but unequivocal diagnosis is difficult (Chap. 5). There are
likely to be diagnostic errors, especially when only data from macroscopic post-
mortems are available and when necropsies are conducted by researchers with limited experience. Assessment of probability of death, when possible, in relation to the
residues in tissues collected from carcasses, may be a means of assessing overall
AR-induced mortality in populations (Chaps. 6 and 7). This is hampered by the fact
that it is unclear whether current reported levels of toxicity are over or under-
estimates. However, what is more likely to be under-detected, or go completely
undetected, is if exposure to ARs elicits behavioural changes that predispose animals to other lethal risks, such as being more easily predated or involved in accidents (e.g., electrocution, vehicular strikes). Quantifying how many individuals
may be “indirectly” affected in this way is a major challenge.
There have been many wildlife studies in which AR tissue residues (primarily in
liver) have been the principal measurements recorded (Chap. 6). These investigations
were conducted to determine the nature and extent of primary and secondary exposure
and comprise the bulk of all the investigations on ARs in wildlife. They have concentrated on exposure rather than effects, probably because of the aforementioned
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difficulties in diagnosing effects. Such residue measurements provide valuable
information on exposure, as the long tissue half-lives of SGARs provide an “exposure
signal” that is integrated over days and months. While liver residues are informative
of exposure, they are of less value for risk assessment where there is a need to estimate dietary AR concentrations for predators. In such cases, total body concentrations of prey animals are recommended, but data on anticoagulant body burdens in
non-target (and often even target) prey species are generally lacking.
It is perhaps surprising that there have been comparatively few studies on primary exposure in wildlife (Chap. 6) compared with the number on secondary exposure. This is despite the fact that primary exposure is likely to result in higher dose
rates to individuals than secondary exposure and would probably be more likely to
cause acute mortalities. The studies that have been conducted indicate that the taxa
most at risk of primary exposure include invertebrates, reptiles, birds and mammals.
Comparatively little is known about primary exposure and effects in invertebrates,
reptiles or even birds; hence further investigations are needed. Studies on non-target
small mammals indicate that there are both key ecological (Chap. 6) and landscape
(Chap. 8) interactions between bait placement and receptor species that influence
primary exposure. Typically, it is the more granivorous/herbivorous species that are
most widely exposed, as the vast majority of AR use involves the application of
cereal baits. Other types of baits are used in and around buildings, which may result
in other species being exposed, including more omnivorous and even carnivorous
species. This may play an important role in more urban areas. Animals foraging
close to bait stations, typically within 100 metres, are more likely to be exposed to
ARs, although this distance can be greater for the more mobile rodent and other
species for example birds, and can depend on habitat configuration. In contrast,
localised spatial interactions are less important when considering aerial bait applications, because of the large-scale and relatively indiscriminate nature of bait distribution. However, co-occurrence between non-target animals and AR treatments
does not mean that exposure to ARs actually occurs because species traits, such as
dietary and habitat preferences, home range size and mobility, all influence the likelihood of exposure. Adoption of a trait-based approach, together with consideration
of the spatial interactions between the compound and non-target species, are likely
to both enhance a priori identification of primary exposure risk and help identify
appropriate mitigation measures. It is notable that studies to date suggest a surprisingly high degree of exposure (as evidenced by tissue residues) in shrews and
hedgehogs, which are predominantly insectivorous, a trait that would not indicate
high likelihood of exposure (Chaps. 6). Exposure in shrews and hedgehogs may be
both primary and secondary through consumption of contaminated insects, and possibly carrion. It is possible that specialist feeders are more plastic in their diet selection, and that exposure through multiple pathways is more common for many
individuals, than is presumed.
Overall, it is evident from a range of studies that primary exposure can lead to
acute mortalities in non-targets and, in some instances, has caused declines in species abundance (Chaps. 6 and 7). Populations are likely to recover partly through
reduced density-dependent mortality, and such recovery may be relatively rapid in
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species with high intrinsic rates of reproduction. In non-isolated populations, immigration may also contribute to recovery. However, prolonged or permanent baiting
can exert a continuous mortality pressure, and may encourage immigration into
what effectively become ecological sink areas. Further studies are needed to quantify the interaction between baiting practices (e.g., formulation, placement, density
and especially duration) and population effects. Furthermore, given the unexpected
high occurrence of residues in shrews and hedgehogs, there is a need to determine
if small insectivores are particularly susceptible to AR exposure, accumulation or
effects.
It might be expected that secondary exposure in predators would reflect opportunistic feeding behaviour and the highly variable nature of primary exposure in prey.
However, the often greater life-span and larger foraging areas of predators compared with prey, coupled with the bioaccumulation of ARs in tissues such as the
liver, mean that secondary exposure is integrated both temporally and spatially. This
explains the finding that 58% (2414 out of 4187) of predators analyzed in worldwide field monitoring studies have AR tissue residues, evidence that secondary
exposure to ARs in populations of predators is a global phenomenon (Chap. 7).
Because of the diversity of their prey, not all of which feed on rodenticides, exposure might be expected to be lower in generalist predators than in rodent-specialists.
A review of the literature indeed suggests that the proportion of animals exposed is
greatest in mammals that specialize on rodents and less in non-specialist mammals;
interestingly, this difference between generalists and specialists was not apparent in
birds. Studies further suggest that the most “at-risk” predators are nocturnal opportunistic predators for which rodents are a key component of their diet, seasonally or
year-round. The ecological factors that drive the uptake of ARs in predators and
likelihood of exposure (Chap. 9) are context specific. They depend on the landscape
that the predators inhabit and the management of habitats within that landscape. For
example, there is significant potential for ARs to move into food-chains when they
are mass-applied to agricultural fields, but predators that consume rats and hunt in
urban environments, where rodent control is commonplace, may be disproportionately exposed. In general, the likelihood of exposure in predators will vary with the
scale and duration of bait availability to prey, the proportion of prey exposed, the
temporal trends in prey density, the foraging tactics of predators, and the propensity
of poisoned rodents to be captured and consumed.
Diagnosis of lethal secondary poisoning is difficult, as discussed earlier and in
detail in Chap. 5, and so the extent to which secondary exposure causes mortalities
in non-target predators is uncertain. Liver AR residues tend to be higher in mammals than birds but it is not clear if this is a reflection of differences in exposure,
bioaccumulation potential, or toxicity. Detection of elevated residues could indicate
either higher exposure or tolerance— more sensitive individuals and species may
die before accumulating high residues, and their carcasses rarely found. Despite
such difficulties in diagnosing fatalities, there have been studies documenting incidents in which relatively large numbers of individual predators have been identified
as having been poisoned by ARs (e.g., Chap. 7). Some island eradications have also
led to AR-mediated population declines of predators; current practices can now
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involve capture, temporary removal and subsequent re-establishment of “at-risk”
species. There remains no clear evidence of population declines that can be directly
attributed to AR poisoning. However, cause-effect relations of chemical exposure
leading to population declines are difficult to detect, attribute and seemingly rare. It
is also argued (Chap. 12) that predator populations released from other pressures,
such as persecution, have rapidly expanded despite their widespread exposure to
ARs, suggesting that any effects caused by ARs may be small in comparison. The
extent to which secondary poisonings may cause demographic effects is likely to
vary among species, and even among populations. However, the global evidence of
exposure, and the uncertainties about the magnitude and drivers of lethal and sub-
lethal poisoning, dictate the need for continued AR monitoring in predators. This
should include monitoring in humans, at least amongst groups that eat large amounts
of game. Furthermore, the role and consequences of AR use on the top-down regulation of rodent populations by predators should also be taken into account when
considering AR use.
Another key factor that has affected the interaction between ARs and wildlife is
intrinsic resistance in target species. The genetic and physiological basis for resistance in target species has been the focus of much study (Chap. 10). The widespread
replacement of FGARs by SGARs is partly the consequence of the development of
resistance to FGARs in target species. This deployment of more potent and persistent SGARs has unquestionably increased the risk to wildlife from rodent control.
There is also a possibility that, because of prolonged exposure, resistant rodent pest
species may accumulate greater AR total body burdens than non-target (presumably
more sensitive) species. However, there are relatively few studies on body burdens
in free-living target species; this remains a knowledge gap. Furthermore, it is likely
that resistance may have indirect effects by prolonging the duration of control campaigns, and thus extending the window of exposure for non-target species. Clearly,
there is a need to monitor the onset of resistance in target species and, where
detected, halt the use of compounds rendered less effective by resistance. The development of molecular techniques to detect resistance now makes conducting large
scale genetic surveillance a reality. Characterisation of the resistance status of
rodent populations can help guide selection of the most efficacious compounds and
control methods.
The overall risk that ARs pose to wildlife is evident from the fact that their use is
now regulated in many countries around the world (Chap. 11). Their continued
authorisation reflects recognition of the benefits delivered by rodent control, and
concerns that regulatory action might prevent access to effective rodent control for
some sectors of society (e.g., lower economic strata) and thus limit associated benefits for health and well-being. While there are alternatives to ARs (Chap. 13) such
as acute rodenticides (acting more rapidly than ARs; e.g., bromethalin, cholecalciferol, strychnine, zinc phosphide), they can also pose a significant hazard through
direct consumption by many species, including people (especially children), livestock, and pets. Forcing a shift from ARs to other chemistries may simply substitute
one set of risks for another. Furthermore, while it is generally accepted that
contamination of wildlife and adverse effects on individuals are undesirable, and to
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regulatory standards in principle unacceptable, the lack of clear evidence of long-
term population-level effects on non-target wildlife raises challenging questions as
to what level of mitigation is actually appropriate and acceptable (Chap. 13). It is
perhaps not surprising therefore that the regulatory response to AR use is not universally agreed upon.
Although application of more stringent risk mitigation measures could pose a
risk to efficacious rodent control, there are various mitigation measures that are
reasonable and could be implemented (Chap. 12). Those include such measures as
bait protection, replacing permanent baiting and its associated constant “leakage” of
ARs into the environment with pulsed baiting that is initiated at the onset of infestation, restricting use by non-professionals, and avoiding use in areas of high non-
target density. Such measures are primarily focused on reducing primary exposure
to non-targets; however, they are unlikely to be particularly efficacious for species
that cannot be prevented from accessing baits. This may be circumvented by increasing focus on prevention of the development of local populations and non-chemical
control of target species, which may decrease the need for chemical control.
Although reductions in non-target primary exposure would be expected to lead to a
concomitant reduction in secondary exposure, this may be partly confounded by the
increased availability of AR-poisoned target rodents to predators and scavengers.
Reduction in secondary exposure may be improved through incorporation of varied
chemical control methods along with pest control practices common in integrated
pest management (IPM). These could include non-chemical control, habitat management, and, in agricultural habitats, the use of lure crops and supplemental feeding. Use of IPM may not only reduce non-target exposure to AR but also benefit
resistance management. Barriers to adoption of IPM approaches include the perception that they do not work, work too slowly or are cumbersome, and are typically
more laborious, expensive and time consuming than simply relying just on application of ARs. Therefore, it is important that the expectations of different stakeholders
are considered and managed. Users may also need to be incentivised further through
better communication about the risks to wildlife from ARs and the likelihood of
resistance in targets that may result from an over-reliance on ARs. However, immediate tangible benefits may also be needed, and one possible option would be to link
implementation of IPM and/or other mitigation measures to existing agricultural
practices through the use of financial subsidy and levy schemes.
Finally, it seems appropriate for this book, in which we have focussed on the
scientific evidence of how ARs affect wildlife, to end by considering key information gaps. These are the gaps that need to be filled to gain a better understanding of
the risk that ARs pose to wildlife and the benefits delivered by mitigation measures
and IPM. In terms of acute effects, better tools are needed to estimate the extent of
AR-induced mortality in different wildlife populations. Currently, the bulk of available data on exposure relates to avian and mammalian predators from predominantly rural environments, yet we still have a poor ability to estimate how ARs
affect those populations. Furthermore, although we know that there can be extensive
sub-lethal exposure of non-target wildlife, we know little about the thresholds (dose
or residues) that cause coagulopathy, and even less about exposure levels that affect
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survival and reproductive fitness. If we in addition consider exposure scenarios and
species about which we have less information, there is a real lack of knowledge
about the extent and importance of exposure in lower vertebrates and invertebrates.
Better information is also needed on exposure of wildlife in urban habitats where
there is probably the greatest density and frequency of AR use, both professional
and amateur. Until these knowledge gaps are better addressed, the discussion over
the need for, or required extent of, mitigation or other interventions will continue.
While lack of this information has the potential to paralyse decision-making about
future interventions, and might be considered a priority, it is interesting to note that
regulatory action and mitigation is proceeding in many countries (Chaps. 11 and
12). That is based on the undesirability of and public opposition to existing wide
scale indiscriminate exposure and the potential loss of wildlife, including species
that are charismatic and of high conservation value. Given that there is already a
move towards mitigation and increased regulation, the key research priority may
ultimately be to address the lack of scientific assessment of the effectiveness of both
specific AR mitigation measures and of IPM approaches to rodent control. Study
trials, monitoring and reporting of the effects of different measures on efficacy of
pest species control, on non-target AR exposure, and on management of resistance,
are sorely needed. If such knowledge gaps can be filled, it should result in a better
understanding of the holistic costs and benefits of chemical and non-chemical control. Ultimately, it will enable us to answer the fundamental questions on how much
rodent control is warranted, of what type, and what are the direct and indirect consequences of such activities on non-target wildlife.

